Why an ALS Drug Was Pulled From the Market Topline data show where sodium phenylbutyrate and taurursodiol fell short Apr 17, 2024
The H5N1 Outbreak Is Not a Test Run, It's a Warning Shot A true public health success would be preventing the virus from further adapting to humans Apr 16, 2024
Bird Flu Is Spreading to More Farm Animals. Are Milk and Eggs Safe? Health officials say the risk to the public is low and the food supply remains safe Apr 15, 2024
FDA Chief Blasted for Infant Formula Crisis Response, COVID Vaccines Republican lawmakers questioned why the agency is "failing to do the bare minimum" Apr 12, 2024
Doc Fired After Deaths; Mass Shooting Blamed on Abortion Law; Record Drug Shortages Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Apr 12, 2024
FDA Expands Approval of Severe Asthma Drug Add-on maintenance therapy benralizumab now indicated for children ages 6 to 11 years as well Apr 11, 2024
After Massive CPAP Recall, Philips Ordered to Overhaul Manufacturing More than 5 million machines have been recalled since 2021 Apr 10, 2024
FDA Approves Earlier Use of CAR-T Products for Myeloma Carvykti and Abecma move to second- and third-line, respectively Apr 08, 2024
Medicare Can Cover Anti-Obesity Drugs for Heart Disease -- But at What Cost? Intense demand coupled with high costs may place pressures on CMS for years to come Apr 08, 2024
Most Cancer Drugs Granted Accelerated Approval Fail Confirmatory Trials Only 43% showed clinical benefit within 5 years Apr 08, 2024
Enhertu Gets Tumor-Agnostic FDA Approval for HER2-Positive Cancers About half of patients responded, duration of response as long as 19 months in three trials Apr 05, 2024
More Bird Flu Spread; FDA to Allow Gay Men to Donate Sperm; 'Oatzempic' Trend Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Apr 05, 2024
Genetic Test for Opioid Addiction Risk Should Be Withdrawn, Experts Tell FDA Methodology behind AvertD DNA test questioned Apr 04, 2024
ALS Therapy to Be Pulled From the Market, Drugmaker Says Patients currently using Relyvrio can transition to a free drug program, Amylyx said Apr 04, 2024
Factor D Inhibitor Wins Approval for PNH With Extravascular Hemolysis Danicopan significantly improved hemoglobin at 12 weeks when added to a C5 inhibitor Apr 04, 2024
FDA OKs Injectable Antibiotic for Three Different Uses Ceftobiprole was at least comparable to currently used medications in studies Apr 03, 2024
Weight-Loss Drug Zepbound Faces Supply Issues Following weight-loss indication, patients struggle to obtain tirzepatide Apr 02, 2024
FDA Warning Letters Detail Controversy at Psychiatric Institute Two letters - one to a psychiatrist - follow reports of a trial participant's suicide Apr 02, 2024
Are Federal Agencies Coming for Ketamine Clinics? Compliance plans can help in the face of possible regulatory scrutiny Apr 01, 2024
Here's What OTC Continuous Glucose Monitors Can Do for Our Patients FDA's approval may be a step toward greater access Mar 30, 2024
Sotatercept's FDA Approval a New Chapter for Pulmonary Arterial Hypertension Biologic should arrive on pharmacy shelves before May Mar 27, 2024
FDA Questioned on Elon Musk's Neuralink; OTC Pain Relief Warning; Easter Egg Safety Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Mar 27, 2024
Overdosing on Chemo: A Common Gene Test Could Save Hundreds of Lives Each Year Treatment can be deadly for enzyme-deficient patients; NCCN doesn't call for preemptive testing Mar 26, 2024
FDA Again Tries to Ban 'Aversive' Shock Treatment Agency proposed a new ban to eliminate shock therapy for self-injurious or aggressive behavior Mar 25, 2024
More Medication Prescribed for Self-Managed Abortion After Roe Fell While in-clinic abortions fell, many found other ways to access care Mar 25, 2024
SCOTUS Again Takes on Issue of Abortion, This Time Over Mifepristone Access Law professor says the case has the potential to upend how drug approvals function Mar 25, 2024
Fixed-Dose Macitentan/Tadalafil Combo Gets FDA Approval for PAH Opsynvi puts two drugs commonly prescribed for pulmonary arterial hypertension into one tablet Mar 25, 2024
FDA Settles Ivermectin Case; When AI Makes a Medical Error; $97,000 Air Ambulance Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Mar 25, 2024
New Monoclonal Authorized to Prevent COVID in Immunocompromised People No such option has been available since FDA revoked the authorization of Evusheld last year Mar 22, 2024
Novel Drug Approved for All Duchenne Muscular Dystrophy Variants Givinostat is the first nonsteroidal drug approved for DMD regardless of genetic mutation Mar 22, 2024
Expanded Label Officially Makes Bempedoic Acid a CVD Prevention Medication New indications supported by CLEAR Outcomes trial Mar 22, 2024
FDA Approves New Frontline Regimen for Aggressive ALL Ponatinib lands indication in combination with chemo for Philadelphia chromosome-positive cases Mar 22, 2024
Graphic Images on Cigarettes of Smoking's Harm Are Constitutional, Court Rules Partial victory for federal regulators seeking to toughen warning labels Mar 22, 2024
House Committee Wrestles With Lab Test Regulation Some favor a proposed FDA rule, while others push for passage of the VALID Act Mar 21, 2024
GOP Lawmakers Blast HHS, Biden for Plans to Loosen Marijuana Restrictions Opposition to Medicaid work requirements also came on the table at a House hearing Mar 21, 2024
Wider Pool of Impella Heart Pumps Caught in Recall After 49 Deaths Devices require label correction for left ventricle perforation risk Mar 21, 2024
Novel Oral Antihypertensive Gets FDA's Blessing Aprocitentan becomes the first endothelin receptor antagonist for BP lowering Mar 20, 2024
Kate Middleton's Medical Records; FDA Syringe Warning; NIH Ends COVID Guidelines Health news and commentary from around the Web gathered by Â鶹´«Ã½ staff Mar 20, 2024
Pediatric Neuron Disease Gets Its First Gene Therapy FDA approves arsa-cel for metachromatic leukodystrophy Mar 18, 2024
First Treatment Approved for Chronic Rhinosinusitis Without Nasal Polyps Daily sprays of Xhance reduced acute exacerbations by 56% to 66% in trials Mar 18, 2024